依据身体质量指数高于或低于25，研究员将参与者分成了两组：偏瘦组和超重组。
Researchers divided the groups into two categories: lean and overweight, depending on whether their BMI was above or below 25.
方法将DM大鼠随机分为西洛他唑治疗组和DM组，用药8周后检测两组血糖、体质量、糖化血红蛋白、心脏重量指数，观察其心肌细胞超微结构变化。
DM rats were randomly divided into cilostazol group and DM group. 8 weeks after treatment, blood glucose, body weight, HbA1c, cardiac weight index and ultrastructure of myocardiocyt were observed.
应用推荐